Eagle Health Investments LP Mirati Therapeutics, Inc. Transaction History

Eagle Health Investments LP

  • $527 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$39.16 - $88.71 $2.04 Million - $4.61 Million
-52,000 Closed
0 $0
Q3 2021

Oct 20, 2021
SELL
$132.13 - $177.45 $779,567 - $1.05 Million
-5,900 Reduced 10.19%
52,000 $9.2 Million
Q2 2021

Jul 19, 2021
BUY
$144.0 - $179.73 $3.1 Million - $3.86 Million
21,500 Added 59.07%
57,900 $9.35 Million
Q1 2021

Apr 23, 2021
BUY
$158.92 - $221.61 $5.78 Million - $8.07 Million
36,400 New
36,400 $6.24 Million

Others Institutions Holding MRTX

# of Institutions
16
Shares Held
3.57M
Call Options Held
0
Put Options Held
36.6K
View Full List

About Mirati Therapeutics, Inc.

MRTX Quotes by TradingView
  • Ticker MRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,609,800
  • Description
  • Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...
More about MRTX
Track This Portfolio

Track Eagle Health Investments LP Portfolio

Follow Eagle Health Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Health Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Health Investments LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email